These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19087296)

  • 1. Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.
    Bruyère O; Burlet N; Delmas PD; Rizzoli R; Cooper C; Reginster JY
    BMC Musculoskelet Disord; 2008 Dec; 9():165. PubMed ID: 19087296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Review of the evidence about drugs used as SYSADOA].
    Sanfélix-Gimeno G; Reig-Mollá B; Sanfélix-Genovés J; Giner-Ruiz V
    Med Clin (Barc); 2007 Nov; 129(16):624-8. PubMed ID: 18001676
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical review of chondroitin sulfate in osteoarthritis.
    Uebelhart D
    Osteoarthritis Cartilage; 2008; 16 Suppl 3():S19-21. PubMed ID: 18674931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis.
    Honvo G; Reginster JY; Rabenda V; Geerinck A; Mkinsi O; Charles A; Rizzoli R; Cooper C; Avouac B; Bruyère O
    Drugs Aging; 2019 Apr; 36(Suppl 1):65-99. PubMed ID: 31073924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SYSADOA place in degenerative-dystrophic joints diseases treatment of neurological practice from the standpoint of evidence-based medicine].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):38-45. PubMed ID: 35394718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of various SYSADOA for the osteoarthritis treatment: an experimental study in rabbits.
    Permuy M; Guede D; López-Peña M; Muñoz F; Caeiro JR; González-Cantalapiedra A
    BMC Musculoskelet Disord; 2015 May; 16():120. PubMed ID: 25986068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucosamine/chondroitin/primorine combination therapy for osteoarthritis.
    Fox BA; Stephens MM
    Drugs Today (Barc); 2009 Jan; 45(1):21-31. PubMed ID: 19271029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of slow-acting anti-arthritic agents in osteoarthritis (chondroitin sulfate, glucosamine, hyaluronic acid)].
    Aubry-Rozier B
    Rev Med Suisse; 2012 Mar; 8(332):571-2, 574, 576. PubMed ID: 22455150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to the treatment of osteoarthritis: oral glucosamine and chondroitin sulfate.
    Schenck RC
    Instr Course Lect; 2000; 49():491-4. PubMed ID: 10829202
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of osteoarthritis: oral therapies].
    Richette P
    Rev Prat; 2012 May; 62(5):654-60. PubMed ID: 22730795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study.
    Rovati LC; Girolami F; D'Amato M; Giacovelli G
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S34-41. PubMed ID: 26632505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturocetic (glucosamine and chondroitin sulfate) compounds as structure-modifying drugs in the treatment of osteoarthritis.
    Reginster JY; Bruyere O; Lecart MP; Henrotin Y
    Curr Opin Rheumatol; 2003 Sep; 15(5):651-5. PubMed ID: 12960496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of nutriceutical effectiveness in the treatment of osteoarthritis.
    Reginster JY; Gillot V; Bruyere O; Henrotin Y
    Curr Rheumatol Rep; 2000 Dec; 2(6):472-7. PubMed ID: 11123100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and tolerability of chondroitin plus glucosamine and D-002 (beeswax alcohols) in subjects with osteoarthritis symptoms.
    Puente R; Illnait J; Mas R; López E; Mendoza S; Carbajal D; Fernández J; Fernández L; Mesa M; Reyes P; Ruiz D
    Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(2):107-118. PubMed ID: 28657529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate.
    Deal CL; Moskowitz RW
    Rheum Dis Clin North Am; 1999 May; 25(2):379-95. PubMed ID: 10356424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucosamine and risedronate alone or in combination in an experimental rabbit model of osteoarthritis.
    Permuy M; Guede D; López-Peña M; Muñoz F; González-Cantalapiedra A; Caeiro JR
    BMC Vet Res; 2014 Apr; 10():97. PubMed ID: 24766775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Treatment Options for Osteoarthritis.
    Hermann W; Lambova S; Muller-Ladner U
    Curr Rheumatol Rev; 2018; 14(2):108-116. PubMed ID: 28875826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potential role for avocado- and soybean-based nutritional supplements in the management of osteoarthritis: a review.
    DiNubile NA
    Phys Sportsmed; 2010 Jun; 38(2):71-81. PubMed ID: 20631466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Analyses of Pharmaceuticals or Food Supplements Containing Chondroitin Sulfate: Are Their Bioactivities Equivalent?
    Stellavato A; Restaino OF; Vassallo V; Finamore R; Ruosi C; Cassese E; De Rosa M; Schiraldi C
    Adv Ther; 2019 Nov; 36(11):3221-3237. PubMed ID: 31494830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of nutraceuticals in the treatment of osteoarthritis.
    Frech TM; Clegg DO
    Curr Rheumatol Rep; 2007 Apr; 9(1):25-30. PubMed ID: 17437663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.